US Stock MarketDetailed Quotes
TERN Terns Pharmaceuticals
- 5.710
- +0.110+1.96%
Close Nov 21 16:00 ET
- 5.690
- -0.020-0.35%
Post 20:01 ET
485.00MMarket Cap-4838P/E (TTM)
5.790High5.460Low1.58MVolume5.560Open5.600Pre Close8.98MTurnover2.72%Turnover RatioLossP/E (Static)84.94MShares11.40052wk High1.33P/B331.94MFloat Cap3.68052wk Low--Dividend TTM58.13MShs Float28.360Historical High--Div YieldTTM5.89%Amplitude1.450Historical Low5.686Avg Price1Lot Size
About Terns Pharmaceuticals Company
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Company Profile
SymbolTERN
Company NameTerns Pharmaceuticals
Listing DateFeb 5, 2021
Issue Price17.00
Founded2017
CEOMs. Amy Burroughs
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1065 East Hillsdale Boulevard,Suite 100
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-525-5535
Websitehttp://www.ternspharma.com
Company Executives
- Name
- Position
- Salary
- Amy Burroughs
- Chief Executive Officer and Director
- --
- Elona Kogan
- Chief Legal Officer
- --
- Melita Sun Jung
- Chief Business Officer
- --
- Dr. Mark J. Vignola, PhD
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 3.14M
- Dr. Erin Quirk, M.D.
- President and Head of Research and Development
- 4.67M
- David Fellows
- Chairman of the Board
- 340.15K
- Dr. Emil T. Kuriakose, M.D.
- President and Head, Research and Development
- --
- Dr. Radhika Tripuraneni, M.D.,M.P.H.
- Director
- 303.06K
- Heather D. Turner
- Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 298.99K
- Jeffrey B. Kindler, Esq.
- Independent Director
- 304.99K
- Jill M. Quigley, Esq.
- Independent Director
- 306.14K
- Dr. Hongbo Lu, PhD
- Independent Director
- 299.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data